Tag: cloud-based rare disease family registry industry trends

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Cloud-Based Rare Disease Family Registry Market Expansion From $1.64 Billion In 2026 To $3.14 Billion In 2030

The market for cloud-based rare disease family registries has experienced substantial expansion recently, with a projected increase from $1.4 billion in 2025 to $1.65 billion in 2026, reflecting a compound annual growth rate of 17.7%. This upward trajectory during the historical period is largely attributable to the proliferation of rare disease research endeavors, heightened engagement from patient advocacy groups, the broadening of clinical trial infrastructures, greater utilization of electronic data capture technologies, and the fundamental requirement for unified systems to manage patient information.

The market for cloud-based rare disease family registries is projected for significant expansion in the coming years, anticipating an increase to $3.15 billion by 2030, fueled by a compound annual growth rate (CAGR) of 17.5%. This projected increase during the forecast period is largely a consequence of heightened investments directed towards the development of orphan drugs, a surge in the need for real-world evidence, the broadening scope of precision medicine research, the increasing application of AI in data analysis, and a greater emphasis on research models centered around the patient. Key developments anticipated within this timeframe include a greater uptake of cloud-based patient registries, expanded utilization of digital platforms for rare disease research endeavors, enhanced integration between genomic and clinical data sets, improvements in global clinical trial recruitment instruments, and a more pronounced focus on safeguarding data through secure sharing practices.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28178&type=smp

Cloud-Based Rare Disease Family Registry Market Demand Drivers: What Is Fueling Industry Growth?

The expansion of the cloud-based rare disease family registry market is anticipated to be driven by the growing emphasis on precision medicine. This approach to healthcare involves customizing treatment and preventative measures based on an individual’s genetic predispositions, surrounding environmental influences, and personal lifestyle choices. Advances in genomic sequencing technology have significantly contributed to the rise of precision medicine, enabling healthcare professionals to gain a more precise understanding of a patient’s genetic composition. Cloud-based registries for rare diseases play a crucial role in facilitating precision medicine by gathering and consolidating comprehensive patient data, encompassing genetic profiles, clinical histories, and therapeutic interventions. A compelling illustration of this trend emerged in February 2024 when the Personalized Medicine Coalition, a nonprofit entity based in the United States, announced that the U.S. Food and Drug Administration (FDA) had approved 16 novel personalized therapies for individuals suffering from rare diseases during 2023, a substantial increase from the six approvals recorded in 2022; among these newly sanctioned treatments, seven were specifically developed for cancer indications, while three addressed other ailments and conditions. Consequently, the escalating adoption of precision medicine is a key factor spurring the growth within the market for cloud-based rare disease family registries.

Cloud-Based Rare Disease Family Registry Market Categorization By Product Type And Application

The cloud-based rare disease family registry market covered in this report is segmented –

1) By Component: Software, Services

2) By Deployment Mode: Public Cloud, Private Cloud, Hybrid Cloud

3) By Application: Patient Data Management, Research, Clinical Trials, Genetic Data Collection, Other Applications

4) By End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Patient Advocacy Groups, Other End-Users

Subsegments:

1) By Software: Electronic Data Capture, Data Management Platform, Analytics And Reporting Tools, Patient Engagement Tools, Clinical Trial Management System

2) By Services: Implementation And Integration, Training And Support, Data Hosting And Security, Consulting Services, Maintenance And Upgrades

Cloud-Based Rare Disease Family Registry Market Innovation Trends: Which Developments Are Transforming The Industry?

Leading entities within the cloud-based rare disease family registry sector are actively pursuing technological advancements, including the implementation of bilingual federated registries, aiming to furnish patients, families, and researchers with robust, geographically dispersed data environments that foster greater engagement and facilitate immediate data gathering and examination. Such a bilingual federated registry represents a cloud-hosted architecture enabling data localization while accommodating diverse linguistic needs and adherence to local privacy mandates and consent protocols. By way of example, the National Organization for Rare Disorders (NORD), a non-profit organization based in the United States, had scheduled for June 2025 the introduction of two patient registries in Canada, specifically for PKU and MPS. These registries, conceived in partnership with Canadian patient advocacy organizations, researchers, and medical professionals, mark the inaugural instances within the IAMRARE Program to be situated beyond the U.S. Their design prioritizes compliance with provincial consent stipulations, empowers collaborative, real-time data acquisition and analysis, and aims to expedite research initiatives, deepen insights into rare metabolic conditions, and streamline the identification of suitable candidates for clinical studies.

Cloud-Based Rare Disease Family Registry Market Company Landscape And Strategic Competition

Major companies operating in the cloud-based rare disease family registry market are Thermo Fisher Scientific Inc., IQVIA Holdings Inc., ICON plc, Syneos Health Inc., Parexel International Corp., Medidata Solutions Inc., FIGMD Inc., OM1 Inc., Mission Health Labs Inc., TREAT-NMD Global Registries Platform, Seqster PDM Inc., ArborMetrix Inc., OpenClinica LLC, Pulse Infoframe Inc., Oracle Healthcare Pvt. Ltd., QuesGen Systems Inc., FTD Disorders Registry, Castor LLC, Data Registry Services LLC, Fibrolamellar Registry, Rare Central

Access The Complete Cloud-Based Rare Disease Family Registry Market Report:

https://www.thebusinessresearchcompany.com/report/cloud-based-rare-disease-family-registry-global-market-report

Cloud-Based Rare Disease Family Registry Market Geographic Landscape: Which Region Dominates Industry Growth?

North Americawas the largest region in the cloud-based rare disease family registry market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cloud-based rare disease family registry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Cloud-Based Rare Disease Family Registry Market Expansion From $1.64 Billion In 2026 To $3.14 Billion In 2030

The market for cloud-based rare disease family registries has experienced substantial expansion recently, with a projected increase from $1.4 billion in 2025 to $1.65 billion in 2026, reflecting a compound annual growth rate of 17.7%. This upward trajectory during the historical period is largely attributable to the proliferation of rare disease research endeavors, heightened engagement from patient advocacy groups, the broadening of clinical trial infrastructures, greater utilization of electronic data capture technologies, and the fundamental requirement for unified systems to manage patient information.

The market for cloud-based rare disease family registries is projected for significant expansion in the coming years, anticipating an increase to $3.15 billion by 2030, fueled by a compound annual growth rate (CAGR) of 17.5%. This projected increase during the forecast period is largely a consequence of heightened investments directed towards the development of orphan drugs, a surge in the need for real-world evidence, the broadening scope of precision medicine research, the increasing application of AI in data analysis, and a greater emphasis on research models centered around the patient. Key developments anticipated within this timeframe include a greater uptake of cloud-based patient registries, expanded utilization of digital platforms for rare disease research endeavors, enhanced integration between genomic and clinical data sets, improvements in global clinical trial recruitment instruments, and a more pronounced focus on safeguarding data through secure sharing practices.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28178&type=smp

Cloud-Based Rare Disease Family Registry Market Demand Drivers: What Is Fueling Industry Growth?

The expansion of the cloud-based rare disease family registry market is anticipated to be driven by the growing emphasis on precision medicine. This approach to healthcare involves customizing treatment and preventative measures based on an individual’s genetic predispositions, surrounding environmental influences, and personal lifestyle choices. Advances in genomic sequencing technology have significantly contributed to the rise of precision medicine, enabling healthcare professionals to gain a more precise understanding of a patient’s genetic composition. Cloud-based registries for rare diseases play a crucial role in facilitating precision medicine by gathering and consolidating comprehensive patient data, encompassing genetic profiles, clinical histories, and therapeutic interventions. A compelling illustration of this trend emerged in February 2024 when the Personalized Medicine Coalition, a nonprofit entity based in the United States, announced that the U.S. Food and Drug Administration (FDA) had approved 16 novel personalized therapies for individuals suffering from rare diseases during 2023, a substantial increase from the six approvals recorded in 2022; among these newly sanctioned treatments, seven were specifically developed for cancer indications, while three addressed other ailments and conditions. Consequently, the escalating adoption of precision medicine is a key factor spurring the growth within the market for cloud-based rare disease family registries.

Cloud-Based Rare Disease Family Registry Market Categorization By Product Type And Application

The cloud-based rare disease family registry market covered in this report is segmented –

1) By Component: Software, Services

2) By Deployment Mode: Public Cloud, Private Cloud, Hybrid Cloud

3) By Application: Patient Data Management, Research, Clinical Trials, Genetic Data Collection, Other Applications

4) By End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Patient Advocacy Groups, Other End-Users

Subsegments:

1) By Software: Electronic Data Capture, Data Management Platform, Analytics And Reporting Tools, Patient Engagement Tools, Clinical Trial Management System

2) By Services: Implementation And Integration, Training And Support, Data Hosting And Security, Consulting Services, Maintenance And Upgrades

Cloud-Based Rare Disease Family Registry Market Innovation Trends: Which Developments Are Transforming The Industry?

Leading entities within the cloud-based rare disease family registry sector are actively pursuing technological advancements, including the implementation of bilingual federated registries, aiming to furnish patients, families, and researchers with robust, geographically dispersed data environments that foster greater engagement and facilitate immediate data gathering and examination. Such a bilingual federated registry represents a cloud-hosted architecture enabling data localization while accommodating diverse linguistic needs and adherence to local privacy mandates and consent protocols. By way of example, the National Organization for Rare Disorders (NORD), a non-profit organization based in the United States, had scheduled for June 2025 the introduction of two patient registries in Canada, specifically for PKU and MPS. These registries, conceived in partnership with Canadian patient advocacy organizations, researchers, and medical professionals, mark the inaugural instances within the IAMRARE Program to be situated beyond the U.S. Their design prioritizes compliance with provincial consent stipulations, empowers collaborative, real-time data acquisition and analysis, and aims to expedite research initiatives, deepen insights into rare metabolic conditions, and streamline the identification of suitable candidates for clinical studies.

Cloud-Based Rare Disease Family Registry Market Company Landscape And Strategic Competition

Major companies operating in the cloud-based rare disease family registry market are Thermo Fisher Scientific Inc., IQVIA Holdings Inc., ICON plc, Syneos Health Inc., Parexel International Corp., Medidata Solutions Inc., FIGMD Inc., OM1 Inc., Mission Health Labs Inc., TREAT-NMD Global Registries Platform, Seqster PDM Inc., ArborMetrix Inc., OpenClinica LLC, Pulse Infoframe Inc., Oracle Healthcare Pvt. Ltd., QuesGen Systems Inc., FTD Disorders Registry, Castor LLC, Data Registry Services LLC, Fibrolamellar Registry, Rare Central

Access The Complete Cloud-Based Rare Disease Family Registry Market Report:

https://www.thebusinessresearchcompany.com/report/cloud-based-rare-disease-family-registry-global-market-report

Cloud-Based Rare Disease Family Registry Market Geographic Landscape: Which Region Dominates Industry Growth?

North Americawas the largest region in the cloud-based rare disease family registry market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cloud-based rare disease family registry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Cloud-Based Rare Disease Family Registry Market Expansion From $1.64 Billion In 2026 To $3.14 Billion In 2030

The market for cloud-based rare disease family registries has experienced substantial expansion recently, with a projected increase from $1.4 billion in 2025 to $1.65 billion in 2026, reflecting a compound annual growth rate of 17.7%. This upward trajectory during the historical period is largely attributable to the proliferation of rare disease research endeavors, heightened engagement from patient advocacy groups, the broadening of clinical trial infrastructures, greater utilization of electronic data capture technologies, and the fundamental requirement for unified systems to manage patient information.

The market for cloud-based rare disease family registries is projected for significant expansion in the coming years, anticipating an increase to $3.15 billion by 2030, fueled by a compound annual growth rate (CAGR) of 17.5%. This projected increase during the forecast period is largely a consequence of heightened investments directed towards the development of orphan drugs, a surge in the need for real-world evidence, the broadening scope of precision medicine research, the increasing application of AI in data analysis, and a greater emphasis on research models centered around the patient. Key developments anticipated within this timeframe include a greater uptake of cloud-based patient registries, expanded utilization of digital platforms for rare disease research endeavors, enhanced integration between genomic and clinical data sets, improvements in global clinical trial recruitment instruments, and a more pronounced focus on safeguarding data through secure sharing practices.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28178&type=smp

Cloud-Based Rare Disease Family Registry Market Demand Drivers: What Is Fueling Industry Growth?

The expansion of the cloud-based rare disease family registry market is anticipated to be driven by the growing emphasis on precision medicine. This approach to healthcare involves customizing treatment and preventative measures based on an individual’s genetic predispositions, surrounding environmental influences, and personal lifestyle choices. Advances in genomic sequencing technology have significantly contributed to the rise of precision medicine, enabling healthcare professionals to gain a more precise understanding of a patient’s genetic composition. Cloud-based registries for rare diseases play a crucial role in facilitating precision medicine by gathering and consolidating comprehensive patient data, encompassing genetic profiles, clinical histories, and therapeutic interventions. A compelling illustration of this trend emerged in February 2024 when the Personalized Medicine Coalition, a nonprofit entity based in the United States, announced that the U.S. Food and Drug Administration (FDA) had approved 16 novel personalized therapies for individuals suffering from rare diseases during 2023, a substantial increase from the six approvals recorded in 2022; among these newly sanctioned treatments, seven were specifically developed for cancer indications, while three addressed other ailments and conditions. Consequently, the escalating adoption of precision medicine is a key factor spurring the growth within the market for cloud-based rare disease family registries.

Cloud-Based Rare Disease Family Registry Market Categorization By Product Type And Application

The cloud-based rare disease family registry market covered in this report is segmented –

1) By Component: Software, Services

2) By Deployment Mode: Public Cloud, Private Cloud, Hybrid Cloud

3) By Application: Patient Data Management, Research, Clinical Trials, Genetic Data Collection, Other Applications

4) By End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Patient Advocacy Groups, Other End-Users

Subsegments:

1) By Software: Electronic Data Capture, Data Management Platform, Analytics And Reporting Tools, Patient Engagement Tools, Clinical Trial Management System

2) By Services: Implementation And Integration, Training And Support, Data Hosting And Security, Consulting Services, Maintenance And Upgrades

Cloud-Based Rare Disease Family Registry Market Innovation Trends: Which Developments Are Transforming The Industry?

Leading entities within the cloud-based rare disease family registry sector are actively pursuing technological advancements, including the implementation of bilingual federated registries, aiming to furnish patients, families, and researchers with robust, geographically dispersed data environments that foster greater engagement and facilitate immediate data gathering and examination. Such a bilingual federated registry represents a cloud-hosted architecture enabling data localization while accommodating diverse linguistic needs and adherence to local privacy mandates and consent protocols. By way of example, the National Organization for Rare Disorders (NORD), a non-profit organization based in the United States, had scheduled for June 2025 the introduction of two patient registries in Canada, specifically for PKU and MPS. These registries, conceived in partnership with Canadian patient advocacy organizations, researchers, and medical professionals, mark the inaugural instances within the IAMRARE Program to be situated beyond the U.S. Their design prioritizes compliance with provincial consent stipulations, empowers collaborative, real-time data acquisition and analysis, and aims to expedite research initiatives, deepen insights into rare metabolic conditions, and streamline the identification of suitable candidates for clinical studies.

Cloud-Based Rare Disease Family Registry Market Company Landscape And Strategic Competition

Major companies operating in the cloud-based rare disease family registry market are Thermo Fisher Scientific Inc., IQVIA Holdings Inc., ICON plc, Syneos Health Inc., Parexel International Corp., Medidata Solutions Inc., FIGMD Inc., OM1 Inc., Mission Health Labs Inc., TREAT-NMD Global Registries Platform, Seqster PDM Inc., ArborMetrix Inc., OpenClinica LLC, Pulse Infoframe Inc., Oracle Healthcare Pvt. Ltd., QuesGen Systems Inc., FTD Disorders Registry, Castor LLC, Data Registry Services LLC, Fibrolamellar Registry, Rare Central

Access The Complete Cloud-Based Rare Disease Family Registry Market Report:

https://www.thebusinessresearchcompany.com/report/cloud-based-rare-disease-family-registry-global-market-report

Cloud-Based Rare Disease Family Registry Market Geographic Landscape: Which Region Dominates Industry Growth?

North Americawas the largest region in the cloud-based rare disease family registry market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cloud-based rare disease family registry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Will The Market Value Of The Cloud-Based Rare Disease Family Registry Market Grow Between 2026 And 2030?

The cloud-based rare disease family registry market has seen significant expansion in recent years. This market is expected to increase from $1.4 billion in 2025 to $1.65 billion in 2026, achieving a compound annual growth rate (CAGR) of 17.7%. The observed growth in the past can be attributed to several factors, including the rise in rare disease research initiatives, greater involvement from patient advocacy, the expansion of clinical trial networks, the growing adoption of electronic data capture tools, and the necessity for centralized patient data systems.

The cloud-based rare disease family registry market size is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $3.15 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.5%. This projected growth during the forecast period is fueled by factors such as enhanced investments in developing orphan drugs, a greater need for generating real-world evidence, the expansion of research in precision medicine, the escalating application of AI-powered data analytics, and a heightened focus on research models centered around patients. Key trends for the forecast period encompass a wider embrace of cloud-based patient registries, an increased utilization of digital platforms for rare disease investigations, the evolving integration of genomic and clinical information, the broadening of global tools for clinical trial recruitment, and a strengthened emphasis on secure data exchange.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/cloud-based-rare-disease-family-registry-global-market-report

Which Primary Drivers Are Impacting The Cloud-Based Rare Disease Family Registry Market Growth?

A growing emphasis on precision medicine is anticipated to drive the expansion of the cloud-based rare disease family registry market in the future. Precision medicine is a medical strategy that customizes treatment and prevention approaches to an individual’s genetic, environmental, and lifestyle factors. Its adoption is increasing due to advancements in genomic sequencing, which enable medical professionals to understand patients’ genetic makeup more precisely. Cloud-based rare disease family registries aid precision medicine by gathering and centralizing comprehensive patient data, including genetic, clinical, and treatment information. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the Food and Drug Administration (FDA), a US-based federal agency, approved 16 new personalized therapies for patients with rare diseases, a significant increase from the six approvals in 2022; of these newly authorized treatments, seven target cancer, while three focus on other diseases and conditions. Therefore, the heightened focus on precision medicine is a key driver for the growth of the cloud-based rare disease family registry market.

How Is The Cloud-Based Rare Disease Family Registry Market Segmented Across Different Segment Categories?

The cloud-based rare disease family registry market covered in this report is segmented –

1) By Component: Software, Services

2) By Deployment Mode: Public Cloud, Private Cloud, Hybrid Cloud

3) By Application: Patient Data Management, Research, Clinical Trials, Genetic Data Collection, Other Applications

4) By End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Patient Advocacy Groups, Other End-Users

Subsegments:

1) By Software: Electronic Data Capture, Data Management Platform, Analytics And Reporting Tools, Patient Engagement Tools, Clinical Trial Management System

2) By Services: Implementation And Integration, Training And Support, Data Hosting And Security, Consulting Services, Maintenance And Upgrades

Which Trends Are Shaping Growth In The Cloud-Based Rare Disease Family Registry Market?

Leading companies in the cloud-based rare disease family registry market are implementing technological advancements, such as bilingual federated registries, to furnish patients, families, and researchers with secure, multi-location data platforms that enhance engagement and facilitate real-time data collection and analysis. A bilingual federated registry functions as a cloud-based system, allowing data to remain at local sites while accommodating multiple languages and adhering to regional consent and privacy regulations. For example, in June 2025, the National Organization for Rare Disorders (NORD), a U.S.-based nonprofit, outlined plans to launch two Canadian patient registries for PKU and MPS. Developed through collaboration with Canadian patient advocacy groups, researchers, and clinicians, these registries mark the first time the IAMRARE Program will be hosted outside the U.S. They are specifically designed to comply with provincial consent requirements, enable cooperative real-time data collection and analysis, and support initiatives to accelerate research, improve the understanding of rare metabolic disorders, and aid in the identification of participants for clinical trials.

Which Organizations Play A Role In The Cloud-Based Rare Disease Family Registry Market Landscape?

Major companies operating in the cloud-based rare disease family registry market are Thermo Fisher Scientific Inc., IQVIA Holdings Inc., ICON plc, Syneos Health Inc., Parexel International Corp., Medidata Solutions Inc., FIGMD Inc., OM1 Inc., Mission Health Labs Inc., TREAT-NMD Global Registries Platform, Seqster PDM Inc., ArborMetrix Inc., OpenClinica LLC, Pulse Infoframe Inc., Oracle Healthcare Pvt. Ltd., QuesGen Systems Inc., FTD Disorders Registry, Castor LLC, Data Registry Services LLC, Fibrolamellar Registry, Rare Central

Get The Full Cloud-Based Rare Disease Family Registry Market Report:

https://www.thebusinessresearchcompany.com/report/cloud-based-rare-disease-family-registry-global-market-report

Which Region Is The Leading Market For The Cloud-Based Rare Disease Family Registry Market?

North America was the largest region in the cloud-based rare disease family registry market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cloud-based rare disease family registry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cloud-Based Rare Disease Family Registry Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/cloud-based-rare-disease-family-registry-global-market-report

Browse Through More Reports Similar to the Global Cloud-Based Rare Disease Family Registry Market 2026, By The Business Research Company

Rare Diseases Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-diseases-treatment-global-market-report

Patient Registry Software Market Report 2026

https://www.thebusinessresearchcompany.com/report/patient-registry-software-global-market-report

Disease Management Apps Market Report 2026

https://www.thebusinessresearchcompany.com/report/disease-management-apps-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Cloud-Based Rare Disease Family Registry Market Expected To Change Between 2026 And 2030?

The cloud-based rare disease family registry market has demonstrated significant expansion in recent years. It is anticipated to increase from $1.4 billion in 2025 to $1.65 billion in 2026, driven by a compound annual growth rate (CAGR) of 17.7%. The historical growth of this market can be ascribed to several factors, including the proliferation of rare disease research initiatives, heightened patient advocacy involvement, the enlargement of clinical trial networks, the increasing adoption of electronic data capture tools, and the necessity for centralized patient data systems.

The cloud-based rare disease family registry market is poised for significant expansion in the upcoming years. This sector is forecast to swell to $3.15 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 17.5%. This anticipated growth is driven by factors such as heightened investments in orphan drug development, a burgeoning demand for real-world evidence generation, the widening scope of precision medicine research, the increasing application of AI-driven data analytics, and a greater focus on patient-centric research models. Over the forecast period, prominent trends are expected to include the broader uptake of cloud-based patient registries, an increased reliance on digital platforms for rare disease research, deeper integration of genomic and clinical data, the expansion of global clinical trial recruitment tools, and a reinforced emphasis on secure data sharing.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28178&type=smp

Which Major Factors Are Driving The Expansion Of The Cloud-Based Rare Disease Family Registry Market?

The growing emphasis on precision medicine is anticipated to propel the expansion of the cloud-based rare disease family registry market moving forward. Precision medicine is a medical strategy that customizes treatment and prevention plans to an individual’s genetic, environmental, and lifestyle factors. The adoption of precision medicine is increasing due to advancements in genomic sequencing, which enable doctors to understand patients’ genetic makeup more accurately. Cloud-based rare disease family registries facilitate precision medicine by collecting and centralizing comprehensive patient data, including genetic, clinical, and treatment information. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the Food and Drug Administration (FDA), a US-based federal agency, approved 16 new personalized therapies for patients with rare diseases. This marked a notable rise from the six approvals in 2022; of these newly authorized treatments, seven target cancer, while three focus on other diseases and conditions. Therefore, the increasing focus on precision medicine is driving the growth of the cloud-based rare disease family registry market.

How Is The Cloud-Based Rare Disease Family Registry Market Structured Across Different Segments?

The cloud-based rare disease family registry market covered in this report is segmented –

1) By Component: Software, Services

2) By Deployment Mode: Public Cloud, Private Cloud, Hybrid Cloud

3) By Application: Patient Data Management, Research, Clinical Trials, Genetic Data Collection, Other Applications

4) By End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Patient Advocacy Groups, Other End-Users

Subsegments:

1) By Software: Electronic Data Capture, Data Management Platform, Analytics And Reporting Tools, Patient Engagement Tools, Clinical Trial Management System

2) By Services: Implementation And Integration, Training And Support, Data Hosting And Security, Consulting Services, Maintenance And Upgrades

What Trends Are Advancing Progress In The Cloud-Based Rare Disease Family Registry Market?

Major companies in the cloud-based rare disease family registry market are advancing technological innovations, such as bilingual federated registries. These innovations provide patients, families, and researchers with secure, multi-location data platforms that enhance participation and support real-time data collection and analysis. A bilingual federated registry is a cloud-based system that allows data to remain at local sites while supporting multiple languages and complying with regional consent and privacy regulations. For instance, in June 2025, the National Organization for Rare Disorders (NORD), a U.S.-based nonprofit, planned the launch of two Canadian patient registries for PKU and MPS. Developed in collaboration with Canadian patient advocacy groups, researchers, and clinicians, these registries are the first in the IAMRARE Program to be hosted outside the U.S. They are designed to comply with provincial consent requirements, enable cooperative real-time data collection and analysis, and support efforts to accelerate research, improve understanding of rare metabolic disorders, and facilitate identification of participants for clinical trials.

Which Major Players Dominate The Cloud-Based Rare Disease Family Registry Market?

Major companies operating in the cloud-based rare disease family registry market are Thermo Fisher Scientific Inc., IQVIA Holdings Inc., ICON plc, Syneos Health Inc., Parexel International Corp., Medidata Solutions Inc., FIGMD Inc., OM1 Inc., Mission Health Labs Inc., TREAT-NMD Global Registries Platform, Seqster PDM Inc., ArborMetrix Inc., OpenClinica LLC, Pulse Infoframe Inc., Oracle Healthcare Pvt. Ltd., QuesGen Systems Inc., FTD Disorders Registry, Castor LLC, Data Registry Services LLC, Fibrolamellar Registry, Rare Central

Read the full cloud-based rare disease family registry market report here:

https://www.thebusinessresearchcompany.com/report/cloud-based-rare-disease-family-registry-global-market-report

Which Region Currently Holds The Largest Share Of The Cloud-Based Rare Disease Family Registry Market?

North America was the largest region in the cloud-based rare disease family registry market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cloud-based rare disease family registry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cloud-Based Rare Disease Family Registry Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28178&type=smp

Browse Through More Reports Similar to the Global Cloud-Based Rare Disease Family Registry Market 2026, By The Business Research Company

Cloud Based Data Management Services Global Market Report

https://www.thebusinessresearchcompany.com/report/cloud-based-data-management-services-global-market-report

Healthcare Cloud Infrastructure Global Market Report

https://www.thebusinessresearchcompany.com/report/healthcare-cloud-infrastructure-global-market-report

Facility Management Services Global Market Report

https://www.thebusinessresearchcompany.com/report/facility-management-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model